Cannasen CBD

Cannasen CBD is a Danish company that develops topical and intranasal products containing cannabidiol (CBD). It was founded in 2011 and is based in Copenhagen, where its development and manufacturing are carried out [2]. Rather than positioning itself as a conventional cosmetics house, the company registers most of its range as over-the-counter medical devices, alongside a smaller sub-line classified as cosmetics [1].

The products are aimed at skin, pain and nasal complaints linked to autoimmune and stress-related conditions. According to the company, its overarching purpose is to improve the quality of life of people dealing with such disorders, using what it describes as effective, natural and safe treatments [1]. The brand remains active.

Cannasen was founded in 2011 by Danish sisters Lone Henriksen, a scientist, and Gitte Lund Henriksen, an economist, who set out to investigate what the company calls the healing potential of Cannabis sativa L. and the workings of the endocannabinoid system — the network the brand associates with mood, pain perception, sleep and immune function [2]. From 2015 the founders began studying CBD formulas in Los Angeles, working with partner experts there and in Argentina, India and Germany [2].

The company frames its mission as exploring the healing potential of cannabinoids and deepening understanding of the endocannabinoid system, with the stated aim of enabling people to live with less pain [2]. It is deliberate about the form its products take: Cannasen sells topical and intranasal preparations, and explicitly not ingestibles, oils or edibles [1]. Its catalogue is organised around conditions — hair loss, pain, arthritis, psoriasis, wound care and nasal health — rather than around beauty routines.

CBD is the primary active ingredient across the range [3]. Two items are registered as cosmetics — an Anti-Hair Loss Serum and a PSO+Atopic Skin Relief Lotion — while the wider medical-device catalogue includes a Pain & Arthritis Gel, a Pain Patch, a Psoriasis Gel, a Wound Gel, a Nasal Spray Night, a Protective Nasal Gel and Infect Protect Lozenges.

On the technical side, the company points to an "optimized concentration of crystalized CBD" intended to improve how well the compound is absorbed through the skin and nasal passages [2], and says a patent is pending on seven of its products [3]. Raw material is grown through the Italian partner Green Valley in the Abruzzo and Veneto regions and extracted by Enecta, with THC content kept below 0.2% [3]. The range carries CE marking, ISO 13485 and GMP certification [2], and the company states that its oral applications are HACCP approved [3]. Cannasen also says its products have been through human clinical trials conducted according to ICH guidelines [2].

Cannasen remains an operationally active brand, developing and selling its cannabinoid-based topical and intranasal products over the counter.